Tanezumab in the treatment of chronic musculoskeletal conditions.
Expert Opin Biol Ther
; 17(2): 245-254, 2017 02.
Article
in En
| MEDLINE
| ID: mdl-27936977
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Musculoskeletal Diseases
/
Receptor, Nerve Growth Factor
/
Antibodies, Monoclonal, Humanized
Limits:
Animals
/
Humans
Language:
En
Journal:
Expert Opin Biol Ther
Journal subject:
BIOLOGIA
/
TERAPEUTICA
Year:
2017
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom